Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced Cancer
Clinical trial NCT03696771 · COMPLETED
Trial details
- NCT number
- NCT03696771
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2020-10-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.